Wallingford, CT, United States of America

Xiaohong Liu

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaohong Liu. Retrieved from https://idiyas.com/inventor/xiaohong-liu-5ld217qv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Xiaohong Liu

Introduction

Xiaohong Liu is a prominent inventor based in Wallingford, CT (US). She has made significant contributions to the field of medicinal chemistry, particularly through her research on cytotoxic compounds. Her work has the potential to impact cancer treatment and therapeutic development.

Latest Patents

Xiaohong Liu holds a patent for "Cytotoxic xanthone compounds." This invention relates to xanthone compounds isolated from the plant Hochr. (Clusiaceae), a Madagascar plant, which are identified as potent cytotoxic agents. This patent highlights her innovative approach to discovering new therapeutic agents.

Career Highlights

Xiaohong Liu is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. Her role involves extensive research and development in the field of drug discovery, where she applies her expertise to create effective treatments for various diseases.

Collaborations

Throughout her career, Xiaohong has collaborated with notable colleagues, including John E. Leet and Craig R. Fairchild. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.

Conclusion

Xiaohong Liu's work exemplifies the impact of innovative research in the pharmaceutical industry. Her contributions to the development of cytotoxic agents demonstrate her commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…